Blog
CAR-T cell therapy remains viable for patients in lymphoma remission, study finds
For some patients who receive cell therapy such as CAR-T
January 13, 2024
For some patients who receive cell therapy such as CAR-T
Using CRISPR screening, the deubiquitinase ATXN3 was identified as a
The approval of yet another RNA-based vaccine for COVID-19 might
L’une des difficultés qui a entravé le succès des cellules
La tendance des cellules CAR-T à perdre leur fonction au
Scientists have developed a new method for engineering more potent
Despite the significant advances made in recent years, there are
Regeneron Pharmaceuticals Inc. and Intellia Therapeutics Inc. have announced an
There are different types of CRISPR system, and the one
